Respiratory sensitization: Advances in assessing the risk of respiratory inflammation and irritation

Toxicology in Vitro

Volumn 25, Issue 7, 2011, Pages 1251-1258

  Vandebriel, Rob ^a   Callant Cransveld, Conchita ^b   Crommelin, Daan ^c   Diamant, Zuzana ^d   Glazenburg, Berend ^e   Joos, Guy ^f   Kuper, Frieke ^g   Natsch, Andreas ^h   Nijkamp, Frans ⁱ   Noteborn, Hub ^j   Pieters, Raymond ⁱ   Roberts, David ^k   Roggen, Erwin ^l   Rorije, Emiel ^a   Seed, Martin ^m   Sewald, Katharina ⁿ   van den Heuvel, Rosette ^o   van Engelen, Jacqueline ^a   Verstraelen, Sandra ^o   van Loveren, Henk ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b SenterNovem   (Netherlands)

^c LYGATURE   (Netherlands)

^d CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

^e MEDICAL CENTER HAAGLANDEN   (Netherlands)

^f GHENT UNIVERSITY   (Belgium)

^g TNO   (Netherlands)

^h GIVAUDAN SCHWEIZ AG   (Switzerland)

ⁱ UTRECHT UNIVERSITY   (Netherlands)

^j Voedsel en Waren Autoriteit Netherlands   (Netherlands)

^k UNIVERSITY OF LIVERPOOL   (United Kingdom)

^l NOVOZYMES A S   (Denmark)

^m UNIVERSITY OF MANCHESTER   (United Kingdom)

ⁿ FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^o FLEMISH INSTITUTE FOR TECHNOLOGICAL RESEARCH VITO   (Belgium)

more..

Author keywords

ASAT; Asthma; In vitro; In vivo; Integrated testing; QSAR; Respiratory tract; Rhinitis; Risk assessment; Sensitization

Indexed keywords

CONTACT ALLERGEN; IMMUNOGLOBULIN E;

AIRWAY REMODELING; ANIMAL TESTING ALTERNATIVE; BIOSAFETY; BRONCHUS HYPERREACTIVITY; CELL ASSAY; CELLULAR IMMUNITY; DENDRITIC CELL; DISEASE PREDISPOSITION; FUNCTIONAL GENOMICS; HUMAN; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; IN VITRO STUDY; MATHEMATICAL MODEL; MUCOSAL IMMUNITY; NONHUMAN; OCCUPATIONAL ASTHMA; PREDICTIVE VALUE; PROCESS DEVELOPMENT; PROCESS MODEL; QUANTITATIVE ANALYSIS; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REACTION ANALYSIS; RESPIRATORY SENSITIZATION; RESPIRATORY TRACT INFLAMMATION; RESPIRATORY TRACT INJURY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIZATION;

ANIMAL TESTING ALTERNATIVES; HAZARDOUS SUBSTANCES; HUMANS; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY TRACT DISEASES; TOXICITY TESTS;

ANIMALIA;

EID: 84860389211     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2011.04.027     Document Type: Review

References (58)

1. Agius R.M. Why are some low-molecular-weight agents asthmagenic. Occup. Med. 2000, 15:369-384.
2. Arts J., de Koning M., Bloksma N., Kuper C. Respiratory allergy to trimellitic anhydride in rats: concentration-response relationships during elicitation. Inhal. Toxicol. 2004, 16:259-269.
3. Arts J.H., De Jong W.H., Van Triel J.J., Schijf M.A., De Klerk A., Van Loveren H., Kuper C.F. The respiratory local lymph node assay as a tool to study respiratory sensitizers. Toxicol. Sci. 2008, 106:423-434.
4. Bardana E.J. 10 Occupational asthma. J. Allergy Clin. Immunol. 2008, 121:S408-S411.
5. Barnes P.J. Immunology of asthma and chronic obstructive pulmonary disease. Nat. Rev. Immunol. 2008, 8:183-192.
6. Bergström M.A., Ott H., Carlsson A., Neis M., Zwadlo-Klarwasser G., Jonsson C.A., Merk H.F., Karlberg A.T., Baron J.M. A skin-like cytochrome P450 cocktail activates prohaptens to contact allergenic metabolites. J. Invest. Dermatol. 2007, 127:1145-1153.
7. Bessac B.F., Sivula M., von Hehn C.A., Escalera J., Cohn L., Jordt S.E. TRPA1 is a major oxidant sensor in murine airway sensory neurons. J. Clin. Invest. 2008, 118:1899-1910.
8. Bousquet J., Jeffery P.K., Busse W.W., Johnson M., Vignola A.M. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 2000, 161:1720-1745.
9. Cantley L.C., Neel B.G. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:4240-4245.
10. Cook D.N., Bottomly K. Innate immune control of pulmonary dendritic cell trafficking. Proc. Am. Thorac. Soc. 2007, 4:234-239.
11. Crimi E., Spanevello A., Neri M., Ind P.W., Rossi G.A., Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am. J. Respir. Crit. Care Med. 1998, 157:4-9.
12. Cunningham A.R., Cunningham S.L., Consoer D.M., Moss S.T., Karol M.H. Development of an information-intensive structure-activity relationship model and its application to human respiratory chemical sensitizers. SAR QSAR Environ. Res. 2005, 16:273-285.
13. Dearman R.J., Basketter D.A., Kimber I. Differential cytokine production following chronic exposure of mice to chemical respiratory and contact allergens. Immunology 1995, 86:545-550.
14. Dearman R.J., Basketter D.A., Kimber I. Characterization of chemical allergens as a function of divergent cytokine secretion profiles induced in mice. Toxicol. Appl. Pharmacol. 1996, 138:308-316.
15. Fentem J., Chamberlain M., Sangster B. The feasibility of replacing animal testing for assessing consumer safety: a suggested future direction. Altern. Lab. Anim. 2004, 32:617-623.
16. Galvão dos Santos G., Reinders J., Ouwehand K., Rustemeyer T., Scheper R.J., Gibbs S. Progress on the development of human in vitro dendritic cell based assays for assessment of the sensitizing potential of a compound. Toxicol. Appl. Pharmacol. 2009, 236:372-382.
17. Gerberick G.F., Vassallo J.D., Bailey R.E., Chaney J.G., Morrall S.W., Lepoittevin J.P. Development of a peptide reactivity assay for screening contact allergens. Toxicol. Sci. 2004, 81:332-343.
18. Gerberick G.F., Vassallo J.D., Foertsch L.M., Price B.B., Chaney J.G., Lepoittevin J.P. Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach. Toxicol. Sci. 2007, 97:417-427.
19. Graham C., Rosenkranz H.S., Karol M.H. Structure-activity model of chemicals that cause human respiratory sensitization. Regul. Toxicol. Pharmacol. 1997, 26:296-306.
20. Haldar P., Brightling C.E., Hargadon B., Gupta S., Monteiro W., Sousa A., Marshall R.P., Bradding P., Green R.H., Wardlaw A.J., Pavord I.D. Mepolizumab and exacerbations of refractory eosinophilic asthma. N. Engl. J. Med. 2009, 360:973-984.
21. Haldar P., Pavord I.D. Noneosinophilic asthma: a distinct clinical and pathologic phenotype. J. Allergy Clin. Immunol. 2007, 119:1043-1052.
22. Henjakovic M., Martin C., Hoymann H.G., Sewald K., Ressmeyer A.R., Dassow C., Pohlmann G., Krug N., Uhlig S., Braun A. Ex vivo lung function measurements in precision-cut lung slices (PCLS) from chemical allergen-sensitized mice represent a suitable alternative to in vivo studies. Toxicol. Sci. 2008, 106:444-453.
23. Jarvis J., Seed M.J., Elton R., Sawyer L., Agius R. Relationship between chemical structure and the occupational asthma hazard of low molecular weight organic compounds. Occup. Environ. Med. 2005, 62:243-250.
24. Karol M.H., Macina O.T., Cunningham A. Cell and molecular biology of chemical allergy. Ann. Allergy Asthma Immunol. 2001, 87:28-32.
25. Kim S.R., Lee K.S., Park S.J., Min K.H., Lee K.Y., Choe Y.H., Lee Y.R., Kim J.S., Hong S.J., Lee Y.C. PTEN down-regulates IL-17 expression in a murine model of toluene diisocyanate-induced airway disease. J. Immunol. 2007, 179:6820-6829.
26. Kuper C.F., Heijne W.H., Dansen M., Verhoeckx K.C., Boorsma A., Radonjic M., Bruijntjes J., Stierum R., Muijser H., Arts J.H. Molecular characterization of trimellitic anhydride-induced respiratory allergy in Brown Norway rats. Toxicol. Pathol. 2008, 36:985-998.
27. Kuper C.F., Stierum R.H., Boorsma A., Schijf M.A., Prinsen M., Bruijntjes J.P., Bloksma N., Arts J.H. The contact allergen dinitrochlorobenzene (DNCB) and respiratory allergy in the Th2-prone Brown Norway rat. Toxicology 2008, 246:213-221.
28. Kwak Y.G., Song C.H., Yi H.K., Hwang P.H., Kim J.S., Lee K.S., Lee Y.C. Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J. Clin. Invest. 2003, 111:1083-1092.
29. Lambrecht B.N., Hammad H. Taking our breath away: dendritic cells in the pathogenesis of asthma. Nat. Rev. Immunol. 2003, 3:994-1003.
30. Larsson K., Lindstedt M., Borrebaeck C.A. Functional and transcriptional profiling of MUTZ-3, a myeloid cell line acting as a model for dendritic cells. Immunology 2006, 117:156-166.
31. Lee Y.C. The role of PTEN in allergic inflammation. Arch. Immunol. Ther. Exp. (Warsz) 2004, 52:250-254.
32. Lee K.S., Kim S.R., Park S.J., Lee H.K., Park H.S., Min K.H., Jin S.M., Lee Y.C. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) reduces vascular endothelial growth factor expression in allergen-induced airway inflammation. Mol. Pharmacol. 2006, 69:1829-1839.
33. Maestrelli P., Boschetto P., Fabbri L.M., Mapp C.E. Mechanisms of occupational asthma. J. Allergy Clin. Immunol. 2009, 123:531-542.
34. Nassenstein C., Kutschker J., Tumes D., Braun A. Neuro-immune interaction in allergic asthma: role of neurotrophins. Biochem. Soc. Trans. 2006, 34:591-593.
35. Nassenstein C., Kwong K., Taylor-Clark T., Kollarik M., Macglashan D.M., Braun A., Undem B.J. Expression and function of the ion channel TRPA1 in vagal afferent nerves innervating mouse lungs. J. Physiol. 2008, 586:1595-1604.
36. Natsch A., Gfeller H. LC-MS-based characterization of the peptide reactivity of chemicals to improve the in vitro prediction of the skin sensitization potential. Toxicol. Sci. 2008, 106:464-478.
37. Rijnkels J.M., Van den Aker E.C., Burdorf A., Van Wijk R.G., Heederik D.J., Houben G.F., Van Loveren H., Pal T.M., Van Rooij F.G., van Der Zee J.S. Prevention of work-related airway allergies; summary of the advice of the Health Council of the Netherlands. Allergy 2008, 63:1593-1596.
38. Roberts D.W., Aptula A.O., Patlewicz G. Mechanistic applicability domains for non-animal based prediction of toxicological endpoints. QSAR analysis of the schiff base applicability domain for skin sensitization. Chem. Res. Toxicol. 2006, 19:1228-1233.
39. Roberts D.W., Natsch A. High throughput kinetic profiling approach for covalent binding to peptides: application to skin sensitization potency of Michael acceptor electrophiles. Chem. Res. Toxicol. 2009, 22:592-603.
40. Roggen E., Aufderheide M., Cetin Y., Dearman R.J., Gibbs S., Hermanns I., Kimber I., Regal J.F., Rovida C., Warheit D.B., Uhlig S., Casati S. The development of novel approaches to the identification of chemical and protein respiratory allergens. Altern. Lab. Anim. 2008, 36:591-598.
41. Rosi E., Ronchi M.C., Grazzini M., Duranti R., Scano G. Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: results of a factor analysis. J. Allergy Clin. Immunol. 1999, 103:232-237.
42. Schreiner M., Peiser M., Briechle D., Stahlmann R., Zuberbier T., Wanner R. A new dendritic cell type suitable as sentinel of contact allergens. Toxicology 2008, 249:146-152.
43. Seed M.J., Hussey L.J., Lines S.K., Turner S., Agius R.M. Prediction of asthma hazard of glutaraldehyde substitutes. Occup. Med. 2006, 56:284-285.
44. Seed M.J., Cullinan P., Agius R.M. Methods for the prediction of low-molecular-weight occupational respiratory sensitizers. Curr. Opin. Allergy Clin. Immunol. 2008, 8:103-109.
45. Seed M.J., Agius R.M. Prediction of asthma hazard of thiamine. Allergy 2006, 61:648.
46. Seed M.J., Agius R.M. Paradoxical asthma hazard of short-acting beta2-agonists. Allergy 2008, 63:241.
47. Tarlo S.M., Balmes J., Balkissoon R., Beach J., Beckett W., Bernstein D., Blanc P.D., Brooks S.M., Cowl C.T., Daroowalla F., Harber P., Lemiere C., Liss G.M., Pacheco K.A., Redlich C.A., Rowe B., Heitzer J. Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement. Chest 2008, 134:1S-41S.
48. Vandebriel R.J., van Loveren H. Non-animal sensitization testing: state-of-the-art. Crit. Rev. Toxicol. 2010, 40:389-404.
49. Vandebriel R.J., De Jong W.H., Spiekstra S.W., Van Dijk M., Fluitman A., Garssen J., Van Loveren H. Assessment of preferential T-helper 1 or T-helper 2 induction by low molecular weight compounds using the local lymph node assay in conjunction with RT-PCR and ELISA for interferon-gamma and interleukin-4. Toxicol. Appl. Pharmacol. 2000, 162:77-85.
50. Vandebriel R.J., De Jong W.H., Hendriks J.J., Van Loveren H. Impact of exposure duration by low molecular weight compounds on interferon-gamma and interleukin-4 mRNA expression and production in the draining lymph nodes of mice. Toxicology 2003, 188:1-13.
51. Van Och F.M., Van Loveren H., De Jong W.H., Vandebriel R.J. Cytokine production induced by low-molecular-weight chemicals as a function of the stimulation index in a modified local lymph node assay: An approach to discriminate contact sensitizers from respiratory sensitizers. Toxicol. Appl. Pharmacol. 2002, 184:46-56.
52. Veres T.Z., Rochlitzer S., Shevchenko M., Fuchs B., Prenzler F., Nassenstein C., Fischer A., Welker L., Holz O., Müller M., Krug N., Braun A. Spatial interactions between dendritic cells and sensory nerves in allergic airway inflammation. Am. J. Respir. Cell. Mol. Biol. 2007, 37:553-561.
53. Veres T.Z., Shevchenko M., Krasteva G., Spies E., Prenzler F., Rochlitzer S., Tschernig T., Krug N., Kummer W., Braun A. Dendritic cell-nerve clusters are sites of T cell proliferation in allergic airway inflammation. Am. J. Pathol. 2009, 174:808-817.
54. Verstraelen S., Nelissen I., Hooyberghs J., Witters H., Schoeters G., Van Cauwenberge P., Van Den Heuvel R. Gene profiles of a human bronchial epithelial cell line after in vitro exposure to respiratory (non-) sensitizing chemicals: identification of discriminating genetic markers and pathway analysis. Toxicology 2009, 255:151-159.
55. Verstraelen S., Nelissen I., Hooyberghs J., Witters H., Schoeters G., Van Cauwenberge P., Van Den Heuvel R. Gene profiles of a human alveolar epithelial cell line after in vitro exposure to respiratory (non-) sensitizing chemicals: identification of discriminating genetic markers and pathway analysis. Toxicol. Lett. 2009, 185:16-22.
56. Verstraelen S., Nelissen I., Hooyberghs J., Witters H., Schoeters G., Van Cauwenberge P., Van Den Heuvel R. Gene profiles of THP-1 macrophages after in vitro exposure to respiratory (non-)sensitizing chemicals: identification of discriminating genetic markers and pathway analysis. Toxicol. In Vitro 2009, 23:1151-1162.
57. Widdicombe J.G. Overview of neural pathways in allergy and asthma. Pulm. Pharmacol. Ther. 2003, 16:23-30.
58. Yamada K.M., Araki M. Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis. J. Cell. Sci. 2001, 114:2375-2382.